We are live on
!
Find out more
AbbVie
ABBV
ABBV
3,106 hedge funds and large institutions have $183B invested in AbbVie in 2023 Q3 according to their latest regulatory filings, with 175 funds opening new positions, 1,276 increasing their positions, 1,278 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 3,074 → 3,106 (+32)
0.19% more ownership
Funds ownership: 69.4% → 69.59% (+0.19%)
0% less repeat investments, than reductions
Existing positions increased: 1,276 | Existing positions reduced: 1,278
Holders
3,106
Holding in Top 10
224
Calls
$3.77B
Puts
$2.19B
Top Buyers
| 1 | +$883M | |
| 2 | +$441M | |
| 3 | +$213M | |
| 4 |
Goldman Sachs
New York
|
+$208M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$184M |
Top Sellers
| 1 | -$238M | |
| 2 | -$226M | |
| 3 | -$217M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$179M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$173M |